Zhuhai Sailong Pharmaceutical Co Ltd

Sailong Pharmaceutical Group Co., Ltd. researches, develops, produces, markets, and services pharmaceutical intermediates, raw materials, and preparations in China. Its products include esomeprazole sodium, ornithine aspartate, thymus, argatroban, tigecycline, monosialotetrahexose ganglioside sodium, cerebroprotein hydrolysate, milrinone, parecoxib sodium, tranexamic acid, clindamycin phosphate, and pantoprazole sodium. These products serve therapeutic areas such as cardiovascular, cerebrovascular, nerve, and digestive system treatments, proton pump inhibitors, anti-infectives, anti-bleeding drugs, and analgesics. Formerly known as Zhuhai Sailong Pharmaceutical Co., Ltd., the company changed its name to Sailong Pharmaceutical Group Co., Ltd. in September 2021; it was founded in 2002 and is based in Zhuhai, China.